These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9063482)

  • 1. [Biochemical mechanisms of NCS-chromophore-induced DNA cleavage and inhibition of protein kinase activity].
    Ohtsuki K; Tanoue S; Karino A
    Gan To Kagaku Ryoho; 1997 Feb; 24(4):443-53. PubMed ID: 9063482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanism of novel DNA sugar damage by an antitumour protein antibiotic.
    Goldberg IH; Kappen LS; Povirk LF; Chin DH
    Drugs Exp Clin Res; 1986; 12(6-7):495-505. PubMed ID: 2943568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New complex of post-activated neocarzinostatin chromophore with DNA: bulge DNA binding from the minor groove.
    Kwon Y; Xi Z; Kappen LS; Goldberg IH; Gao X
    Biochemistry; 2003 Feb; 42(5):1186-98. PubMed ID: 12564921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a covalent monoadduct of neocarzinostatin chromophore at a DNA bulge.
    Kappen LS; Goldberg IH
    Biochemistry; 1997 Dec; 36(48):14861-7. PubMed ID: 9398208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neocarzinostatin chromophore. Assignment of spectral properties and structural requirements for binding to DNA.
    Napier MA; Goldberg IH
    Mol Pharmacol; 1983 Mar; 23(2):500-10. PubMed ID: 6220205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a novel covalent monoadduct on the RNA overhang of an RNA-DNA hybrid induced by antitumor antibiotic neocarzinostatin.
    Zheng P; Liu CL; Xi Z; Smith RD; Goldberg IH
    Biochemistry; 1998 Feb; 37(6):1706-13. PubMed ID: 9484242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biochemical mechanisms of the DNA cleavage induced by NCS-chromophore].
    Ohtsuki K
    Seikagaku; 1996 Dec; 68(12):1817-24. PubMed ID: 9014491
    [No Abstract]   [Full Text] [Related]  

  • 8. Neocarzinostatin induces an effective p53-dependent response in human papillomavirus-positive cervical cancer cells.
    Bañuelos A; Reyes E; Ocadiz R; Alvarez E; Moreno M; Monroy A; Gariglio P
    J Pharmacol Exp Ther; 2003 Aug; 306(2):671-80. PubMed ID: 12750435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of apoptosis in murine and human neuroblastoma cell lines by the enediyne natural product neocarzinostatin.
    Hartsell TL; Yalowich JC; Ritke MK; Martinez AJ; Schor NF
    J Pharmacol Exp Ther; 1995 Oct; 275(1):479-85. PubMed ID: 7562588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induced formation of a DNA bulge structure by a molecular wedge ligand-postactivated neocarzinostatin chromophore.
    Gao X; Stassinopoulos A; Ji J; Kwon Y; Bare S; Goldberg IH
    Biochemistry; 2002 Apr; 41(16):5131-43. PubMed ID: 11955061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mechanisms of actions of neocarzinostatin (NCS) and NCS-associated nonprotein chromophore (author's transl)].
    Ohtsuki K; Ishida N
    Tanpakushitsu Kakusan Koso; 1981 Jun; 26(7):937-49. PubMed ID: 6457319
    [No Abstract]   [Full Text] [Related]  

  • 12. Probing DNA single strands for single-base bulges with neocarzinostatin chromophore.
    Kappen LS; Xi Z; Goldberg IH
    Biochemistry; 2001 Dec; 40(50):15378-83. PubMed ID: 11735421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additive effects of bleomycin and neocarzinostatin on degradation of DNA, inhibition of DNA polymerase beta, and cell growth.
    Müller WE; Maidhof A; Arendes J; Geurtsen W; Zahn RK; Schmidseder R
    Cancer Res; 1979 Sep; 39(9):3768-73. PubMed ID: 89904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bcl-2-mediated potentiation of neocarzinostatin-induced apoptosis: requirement for caspase-3, sulfhydryl groups, and cleavable Bcl-2.
    Mi Z; Hong B; Mirnics ZK; Tyurina YY; Kagan VE; Liang Y; Schor NF
    Cancer Chemother Pharmacol; 2006 Feb; 57(3):357-67. PubMed ID: 16001169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor mechanisms of zinostatin stimalamer (YM881).
    Tanaka S; Yamamoto M; Numasaki Y
    Res Commun Mol Pathol Pharmacol; 1996 May; 92(2):165-76. PubMed ID: 8774070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular dynamics simulations investigation of neocarzinostatin chromophore-releasing pathways from the holo-NCS protein.
    Zhao X; Wang S; Gao XF; Huang XR; Sun CC
    J Struct Biol; 2010 Jan; 169(1):14-24. PubMed ID: 19747549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding and cleavage characteristics of the complexes formed between the neocarzinostatin chromophore and single site containing oligonucleotides.
    Stassinopoulos A; Goldberg IH
    Bioorg Med Chem; 1995 Jun; 3(6):713-21. PubMed ID: 7582949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanistic studies on the base-catalyzed transformation of neocarzinostatin chromophore: roles of bulged DNA.
    Xi Z; Mao QK; Goldberg IH
    Biochemistry; 1999 Apr; 38(14):4342-54. PubMed ID: 10194353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding specificity of post-activated neocarzinostatin chromophore drug-bulged DNA complex studied using electrospray ionization mass spectrometry.
    Gao Q; Cheng X; Smith RD; Yang CF; Goldberg IH
    J Mass Spectrom; 1996 Jan; 31(1):31-6. PubMed ID: 8799259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid bilayer-assisted release of an enediyne antibiotic from neocarzinostatin chromoprotein.
    Hariharan P; Sudhahar CG; Chou SH; Chin DH
    Biochemistry; 2010 Sep; 49(35):7722-32. PubMed ID: 20712297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.